Cancer Program at UCMC Earns Top CoC Accreditation
The American College of Surgeons (ACoS) Commission on Cancer (CoC) has awarded The University of Chicago Medical Center (UCMC) a Three-Year Accreditation with Commendation.
The UCMC cancer program earned the highest overall rating with commendation in seven areas:
- Outcomes analysis
- Quality of National Cancer Data Base (NCDB) data submission
- College of American Pathologists (CAP) guidelines
- Clinical trial accrual
- Prevention and early detection
- Cancer education for registry staff
- Cancer-related quality improvements
The accreditation is nationally recognized by organizations such as the Joint Commission, American Cancer Society, Centers for Medicare & Medicaid Services, and the National Cancer Institute (NCI) as having established measures for the provision of high-quality cancer care.
“We are honored to receive such a high rating,” said UCCCC Director Michelle Le Beau, PhD. “For our patients, this means they can expect to receive quality, comprehensive care that includes a multidisciplinary team approach, a complete range of state-of-the-art services and treatments, and access to early detection programs, cancer education, and support services.”
The CoC conducted a daylong survey of the UCMC cancer program on May 10 using the UCMC as a pilot facility for ACoS standards that go into effect in 2012.
“Earning such a high rating shows our commitment to quality,” said Dr. Le Beau. “I would especially like to thank the Cancer Registry team, run by Cassie Simon, CTR, and the Cancer Committee, chaired by Kevin Roggin, MD, for their outstanding dedication to continuous quality improvement.”